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Abstract: This paper describes the results of the STRATOB (Systemic and STRATegic psychotherapy for OBesity) study, 
a two-arm randomized controlled clinical trial (RCT) comparing Brief Strategic Therapy (BST, Nardone or Arezzo 
model) with the gold standard CBT (Cognitive Behavioral Therapy) for the inpatient and telephone-based outpatient 
treatment of obese people with Binge Eating Disorder (BED) seeking treatment for weight reduction. Primary outcome 
measure of the randomized trial was change in the Global Index of the Outcome Questionnaire (OQ 45.2). Secondary out-
come measures were BED remission (weekly binge episodes < 2) and weight loss. Data were collected at baseline, at dis-
charge from the hospital (c.a. 1 month after) and after 6 months from discharge.. No significant difference between groups 
(BST vs CBT) was found in the primary outcome at discharge. However, a greater improvement was seen in the BST vs 
the CBT group (P<.01) in the primary outcome at 6 months. About secondary outcomes, no significant difference between 
groups were found in weight change both at discharge and at 6 months. Notably, a significant association emerged be-
tween treatment groups and BED remission at 6 months in favor of BST (only 20% of patients in BST group reported a 
number of weekly binge episodes > 2 vs 63.3% in CBT group).  
Keywords: Brief strategic therapy – BST, cognitive behavioural therapy – CBT, binge-eating disorder – BED, clinical psy-
chology, obesità, telecare, psychotherapy. 
INTRODUCTION 
Obesity constitutes one of the most important medical 
and public health problems of our time [1]. It is considered 
as a chronic pathology and is widely recognized as a risk 
factor for many medical complications such as cardiovascu-
lar, orthopedic, pneumological and endocrinological diseases 
[2-8]. Overweight and obesity is also linked with Binge Eat-
ing Disorder (BED). “Binge eating disorder is characterized 
by frequent and persistent episodes of binge eating accom-
panied by feelings of loss of control and marked distress in 
the absence of regular compensatory behaviors” (p. 94. [9]). 
Functional interventions for significantly reduce weight, 
maintain weight loss and manage associated pathologies like 
BED are tipically combined treatment options (dietetic, nu-
tritional, physical, behavioral, cognitive-behavioral, pharma-
cological, surgical). Significant difficulties with regard to 
availability, costs, treatment adherence and long-term effi-
cacy are present [10]. Moreover, most overweight and obese 
individuals regain about one third of the weight lost with 
treatment within 1 year [11] and they are typically back to 
baseline in 3 to 5 years [12-14]. 
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Treatment for BED is directed towards either the physi-
cal or psychopathological impairments and Cognitive behav-
ior therapy (CBT) and Interpersonal Psychotherapy (IPT) are 
psychotherapies for BED indicated to target the eating disor-
der [9]. Particularly CBT is the therapeutic approach indi-
cated both in inpatient and in outpatient settings for BED 
[15-27]. In recent years systemic and systemic-strategic psy-
chotherapies have been implemented to treat patients with 
obesity and BED involved in familiar problems [26-30]. Par-
ticularly, a brief protocol for the systemic-strategic treatment 
of BED, using overall the strategic dialogue, has been devel-
oped by Nardone and Portelli in the Handbook of Brief Stra-
tegic Therapy (BST) [31].  
Furthermore, telemedicine, a new promising low cost 
method, has been used for obesity with BED in outpatient 
settings in order to avoid relapse after the inpatient step of 
treatment and to keep on a continuity of care with the in-
volvement of the same clinical inpatient team [32-35]. 
For these reasons, we developed STRATOB (Systemic 
and STRATegic psychotherapy for OBesity), a comprehen-
sive two-phase stepped down program enhanced by telepsy-
chology for the mid-term treatment of obese people with 
BED seeking intervention for weight loss. The core aspects 
of STRATOB are the inpatient intensive treatment and the 
continuity of care at home using a low-level of telecare (mo-
bile phones). Many treatments delivered using technologies, 30    Clinical Practice & Epidemiology in Mental Health, 2011, Volume 7  Castelnuovo et al. 
such as web-sites, e-mails, chat lines, videoconferences, 
UMTS-based mobile-phones and telephones, could be a 
valid integration to traditional psychotherapy reducing ex-
pensive and time-consuming clinical visits and improving 
adherence to prescribed psychological, dietetic and medical 
treatments through extensive monitoring and support [10, 12, 
36-41].  
This paper describes the design and the results of the 
STRATOB study, a two-arm randomized controlled clinical 
trial (RCT). The aims of this study are to compare the effec-
tiveness of the BST [31, 42, 43] with the gold standard CBT 
[26, 44-50] in a inpatient and telephone-based outpatient 
program for a sample of obese people with BED seeking 
treatment for weight reduction.   
MATERIALS AND METHODOLOGY 
Study Design and Protocol 
CBT and BST have been compared in a randomized con-
trolled clinical trial. Participants have been randomly allo-
cated in 2 groups: 
1) CBT group: inpatient treatment (diet, physical activity, 
dietitian counseling, 8 sessions of CBT) plus 8 outpatient 
telephone-based sessions of CBT-oriented psychological 
support and monitoring with the same CBT inpatient psycho-
therapists; 
2) BST group: inpatient treatment (diet, physical activity, 
dietitian counseling, 8 sessions of BST) plus 8 outpatient 
telephone-based sessions of BST-oriented psychological 
support and monitoring with the same BST inpatient psycho-
therapists; 
The Medical Ethics Committee of Istituto Auxologico 
Italiano approved the study protocol and the Informed Con-
sents. 
The treatment program considered in this study has a to-
tal duration of 7 months and consists of two stepped down 
phases: in-patient (1 month) and out-patient (the following 6 
months). During the in-patient phase, participants undergo 
an intensive four-week hospital-based and medically-
managed program for weight reduction and rehabilitation. 
Along this period, participants live in a medical hospital-like 
environment located on a mountain highland and far away 
from towns and cities. Visits from parents are allowed only 
in the afternoon. All patients are placed on a hypocaloric 
nutritionally balanced diet tailored to the individual after 
consultation with a dietitian (energy intake around 80% of 
the basal energy expenditure estimated according to the Har-
ris-Benedict equation and a  macronutrient composition of 
about 16% proteins, 25% fat and 59% carbohydrates). Fur-
thermore, they receive nutritional counseling provided by a 
dietitian, psychotherapy provided by psychologists-psycho- 
therapists (well trained in CBT and BST approaches) and 
have physical activity training provided by a physiotherapist.  
Nutritional rehabilitation program aims to improve and 
promote change in eating habits and consists of both indi-
vidual sessions (dietary assessment, evaluation of nutrient 
intake and adequacy, nutritional status, anthropometric, eating 
patterns, history of overweight, readiness to adopt change) 
and group sessions (45 minutes each twice a week) includ-
ing: information on obesity and related health risks, setting 
of realistic goals for weight loss, healthy eating in general, 
general nutrition and core food groups, weight management 
and behavior change strategies for preventing relapse). 
Psychotherapy is provided twice a week in a face-to-face 
setting. CBT individual sessions, lasting 45 minutes each, 
are mainly based on the cognitive-behavioral approach de-
scribed by Cooper and Fairburn [50] and emphasize the 
techniques of self-monitoring, goal setting, time management, 
prompting and cueing, problem solving, cognitive restructur-
ing, stress management and relapse prevention. BST individ-
ual sessions, lasting 45 minutes each, are mainly based on 
the brief strategic approach described by Nardone and 
Portelli [31] and emphasize the techniques of working on 
“attempted solutions” (such as keeping control by abstaining 
from food and continuously striving to exert self-control 
with a subsequent loss of control), using reframing maneu-
vers, inducing fear of fasting rather then bingeing, under-
standing what is maintaining and worsening the problem, 
etc. (p. 105-105, [31]). 
Physical activity takes place once a day except for week-
end and consists of group programs (20 subjects) based on 
postural gymnastics, aerobic activity and walks in the open. 
Inpatients with specific orthopedic complications carry out 
individual activities planned by physiotherapists and articu-
lated in programs of physical therapy, assisted passive and 
active mobilization and isokinetic exercise.  
Low to moderate weight losses are expected at the end of 
the in-patient phase, but it is important to note that weight 
loss is not the primary goal of the in-patient program and 
each patient is made clear about this point at the very begin-
ning of the treatment. Beyond the medical management of 
metabolic risk factors for health such as type 2 diabetes, de-
veloping a sense of autonomy and competence are the pri-
mary purposes of the in-hospital interventions. Patients are 
afforded the skills and tools for change and are supported in 
assigning positive values to healthy behaviors and also in 
aligning them with personal values and lifestyle patterns. 
Just after discharge, participants have 4 telephone calls 
with their psychotherapists along 2 months. From the 3rd to 
the 6th month sessions are scheduled every 30 days. During 
tele-sessions, psychotherapists test the outpatients’ progress, 
their mood, the maintenance of the “good alimentary and 
physical activity habits”, the loss/increase of weight and ask 
about critical moments. Some research indicates that changes 
in behavior (eating and exercise) often follow discrete mo-
ments which have been variably described as life events, life 
crises, teachable moments or epiphanies [51]. Life events 
can lead to weight loss but also to weight gain and qualita-
tive research shows that it is not the event per se that results 
in behavior change but the ways in which this event is ap-
praised and interpreted by the individual [52]. The psycho-
therapists (both CBT and BST) have thus the opportunity to 
discuss with the outpatients about the significant events dur-
ing the telephone calls and cognitively reconstruct dysfunc-
tional appraisals in functional ways.  
In particular, phone-sessions with the psychotherapists 
aim to consolidate strategies and abilities acquired during the 
in-patient phase, to improve self-esteem and self-efficacy, to 
support motivation, to prevent relapse and to provide prob-
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As described, in the outpatient phase of the STRATOB 
program great relevance is given to the psychotherapist-
patient relationship as an important medium and vehicle of 
change [53]. After discharge, out-patients begin to experi-
ence the autonomy and competence to change they develop 
during the in-patient phase and inevitably face resistances 
and barriers. Thanks to telephone calls, out-patients are sup-
ported by the psychotherapists who attended them during the 
in-hospital phase in exploring resistances and barriers they 
experience and in finding functional pathways to cope. Fur-
thermore, out-patients are helped to experience mastery in 
terms of the health behavior change that needs to be engaged. 
Study Population 
Recruitment of the Study Population 
One hundred consecutive female inpatients with obesity 
and BED in the age range of 18-65 years who were referred 
to the single clinical center (Saint Joseph Hospital - Istituto 
Auxologico Italiano) for weight-loss treatment have been 
asked and screened for admission to the study. Patients were 
sequentially recruited in 2008. Of these, 37 did not fulfill 
inclusion criteria and 7 declined to partecipate for other rea-
sons (e.g., time constraints, involvement in other treatments). 
Finally, 60 patients (mean age: 46.05 ± 10.54 years; mean 
weight: 106.95 ± 6.94 kg) entered the treatment phase. 
Inclusion and Exclusion Criteria 
Inpatients were eligible when they met the following in-
clusion criteria at the admission to the hospital: 1) age be-
tween 18 and 65 years; 2) obesity according to the WHO 
criteria (BMI30); 3) BED (DSM-IV-TR criteria) and 4) 
written and informed consent to participate. Exclusion criteria 
for the study are: 1) other severe psychiatric disturbance di-
agnosed by DSM-IV-TR criteria; 2) concurrent medical con-
dition not related to obesity. SCID (Structured Clinical In-
terview for DSM-IV-TR Disorders) I and II [54] were used 
as screening tools for psychiatric disorders and were admin-
istered by an independent clinical psychologist as part of his 
work. 
Randomization Procedure 
All participants were randomly assigned to the CBT or 
BST group. The randomization scheme have been generated 
by using the Web site Randomization.com (www. randomi-
zation.com). Randomization took place after the baseline 
measurements.  
Psychotherapists and Treatment Fidelity 
Treatments were delivered by 4 experienced and char-
tered psychotherapists from diverse backgrounds with spe-
cific training in CBT and BST. Psychotherapists received 
monthly supervision by senior chartered psychotherapists to 
ensure competent and uniform treatment delivery. 
Patient Assessment and Measurements 
Primary outcome measure of the randomized trial is   
change in the Global Index of the Outcome Questionnaire 
(OQ 45.2). Secondary outcome measures are BED remission 
defined as a number of weekly binge episodes < 2 and 
weight loss. Data were collected at baseline, at discharge 
from the hospital (c.a. 1 month after) and after 6 months 
from discharge.  
Weight was assessed with the participant in lightweight 
clothing with shoes removed on a balance beam scale. Data 
collected at 6-month follow-up were collected through tele-
sessions. 
Psychological and Behavioral Assessment 
Participants completed the Outcome Questionnaire (OQ 
45.2) – Italian translation and validation [55, 56] at entry to 
the study and at discharge from the hospital with a self-
report procedure. At 6-month follow-up data have been col-
lected via telephone during the tele-sessions. 
The OQ 45.2 is an self report questionnaire developed by 
Michael Lambert in 1996 [57]. The OQ 45 items version is a 
measure of outcome and it is designed in order to collect 
repeated measures of patient progress during psychotherapy 
and after its conclusion. This instrument is one of the most 
used in psychotherapy research in the U.S. [58]. The OQ 
45.2 is composed by 45 items that form 3 scales: Symptom 
Distress (SD), Interpersonal Relations (IR) e Social Role 
(SR), and a Global Index. The OQ 45.2 is proposed as a brief 
screening and outcome scale that tries to assess the subjec-
tive experience of a person, as well as the way he or she 
functions in the world [57]. The choice of this questionnaire 
has to take into account the need to measure a change in a 
short time (1 month of in-patient treatment) due to psycho-
therapeutic activities. The Italian version of the OQ-45.2 
appears promising as a measure of general psychological 
distress, and it could be used to measure the psychotherapy 
outcome in routine clinical practice. So the Outcome Ques-
tionnaire-45 was developed as a brief measure of client pro-
gress in psychotherapy to address the need for accountability 
in the era of managed care and to improve upon extant out-
come measures. 
Number of weekly binge episodes was assessed with a 
self-report procedure at entry to the study and at discharge 
from the hospital. At 6-month follow-up, data have been 
collected via telephone during the tele-sessions. 
Sample Size Calculation and Statistical Analysis 
Due to the novelty of the application of BST in BED 
treatment, no other RCTs including BST have been carried 
out. So this RCT is similar to a pilot study, typically defined 
as small scale preliminary study, and according to Lackey 
and Wingate [59], a pilot work may use at least the 10% of 
the sample required. Using an A-priori Sample Size Calcula-
tor for Student's t-Test (G*Power 3.1.2 software), 64 partici-
pants per group were needed to detect a difference with an 
estimated Effect Size (Cohen's d) of 0.5, an alpha of 0.05 
two-sided, a desired statistical power of 0.80. We decided 
not to make assumptions on sidedness not having previous 
results about comparison between CBT and BST. Taking 
into account the need of at least 10% of the sample required 
(128 individuals, n=64 per group), 60 persons (n=30 per 
group) were considered enough. 
Descriptive statistics (means ± SD) have been used to de-
scribe the study sample with regard to baseline characteris-
tics (Table 1). The independent samples t test was used to 
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weight at all time-points. Change scores were also examined. 
Chi-square was used to test the association between treat-
ment groups and number of weekly binge episodes  2 at 6 
months. Corrected effect sizes (Hedges) and 95% Confi-
dence Interval were calculated for both between-group and 
with-in group differences. All data analyses were performed 
using the Statistical Package for the Social Sciences (version 
16.0; SPSS, Inc., Chicago, IL). 
RESULTS 
There were no differences between CBT and BST on any 
demographic, diagnostic and other clinical variable at pre-
treatment (Table 1). 
No significant between-group difference was found in 
change scores from baseline to discharge in any variables 
(Table 2). At 6 months, OQ 45.2 Global Index as well as the 
OQ 45.2 Symptom Distress (SD) change scores from dis-
charge were higher in the BST vs the CBT group (p<0,000) 
(Table 2 and Fig. 1).  
Table 3 shows the within-group changes for all the vari-
ables at all time-points. BST group had statistically signifi-
cant improvements from baseline to discharge as well as 
from discharge to 6-month follow-up in all continuous out-
comes. CBT group had significant improvements on all the 
variables but not in the OQ 45.2 Interpersonal Relations (IR) 
change from Baseline to Discharge, in the OQ 45.2 Interper-
sonal Relations (IR) change from Discharge to 6 months and 
in Percentage of weight loss from discharge to 6 months 
(95% confidence intervals of mean changes include zero). 
With respect to absolute weight loss, no significant be-
tween-group difference was found in weight loss from base-
line to discharge and from discharge to 6 months (Fig. 2). A 
significant association was found between treatment groups 
and BED remission at 6 months (Fig. 3). In the BST group, 
only 20% of participants vs 63,3% in the CBT group 
(p=0,001) reported a number of weekly binge episodes over 
the cut-off (>2) for the BED diagnosis. 
DISCUSSION AND LIMITATIONS 
Due to the novelty of Brief Strategic Therapy (BST) in 
the treatment of Binge Eating Disorder, no well defined hy-
pothesis have been established about the possible contribu-
tion of this kind of therapy in comparison with Cognitive 
Behavior Therapy (CBT), the “gold standard” psychological 
treatment for BED. With the development of a brief sys-
temic-strategic clinical protocol for treatment of BED [31], 
new interventions in the field of eating disorders are avail-
able and have to be evaluated. Systemic and systemic-
strategic psychotherapies such as BST traditionally focus on 
systemic-family problems and contexts and these areas of 
interventions could represent a real added value in compari-
son with CBT. 
Moreover, BST sessions emphasize the techniques of 
working on “attempted solutions”, using reframing maneu-
vers, inducing fear of fasting rather then bingeing, under-
standing what is maintaining and worsening the problem, 
etc. (p. 105-106, [31]). This focus on “attempted solutions”, 
that in the typical BED are related to dysfunctional habits 
such as “trying to keep control by abstaining from food and 
continuously striving to exert self-control with a subsequent 
loss of control”, could explain the observed superiority of 
BST vs CBT in producing a significant remission of weekly 
binge episodes at 6 months. During the inpatient phase pa-
tients did not cope with the binge temptations due to the lack 
of them in a safe place like the hospital. However, after dis-
charge, patients went back home and faced again with their 
temptations. BST suggestions about managing binge eating 
was proved to be more effective in preventing relapse than 
CBT after 6 months from discharge.  
The other significant difference in favor of BST, i.e. the 
higher improvement in the OQ 45.2 Global Index at 6 
months, is probably due to the focus of BST on symptoms 
reduction (in particular anxiety and depression) in short time 
(traditionally 6-months). Indeed, a significant difference be-
tween CBT and BST was found also in the OQ 45.2 Symp-
tom Distress (SD) scale, where greater improvements were 
seen in the BST vs the CBT group (p<.01). 
The real therapeutic impact of CBT and BST could have 
been significantly reduced by the use of an unusual setting in 
the second phase of the trial. Even if telecare could represent 
a great opportunity for the continuity of treatments “moving 
the healthcare where it really needs”, the limitations of non-
verbal communications, due to the use of telephone sessions, 
could have influenced the CBT and BST protocols  
Table 1.  Baseline Participant Characteristics by Treatment Group 
Characteristic  CBT Group (n = 30)  BST Group (n = 30)  Total (N = 60) 
Age, y *  46,2 (10,5)  45,9 (10,76)  46,05 (10, 54) 
Female sex  30 30  60 
Weight, Kg *  107, 37 (6,83)  106,53 (7,14)  106,95 (6,95) 
OQ 45.2 Symptom Distress (SD) *  48,47 (8,42)  52,13 (11,19)  50,3 (10) 
OQ 45.2 Interpersonal Relations (IR) *  24,40 (5,8)  25,93 (7,61)  25,17 (6,75) 
OQ 45.2 Social Role (SR) *  19,50 (4,47)  18,4 (4,64)  18,95 (4,55) 
OQ 45.2 Global Index *  92,37 (11,01)  96,47 (10,22)  94,42 (10,73) 
Number of weekly binge episodes *  2,83 (0,74)  2,8 (0,8)  2,82 (0,77) 
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Table 2.  Differences Between CBT and BST Groups Considering Primary Outcome Measure (Change in the Global Index and 
Other Sub-Indexes of the OQ 45.2) and Secondary Outcome Measures (Percentage of BED Patients Remitted Considering 
the Number of Weekly Binge Episodes and the Weight Loss) at Discharge from the Hospital and After 6 Months 
 
95% CI 
Outcomes (Primary and Secondaries) 
  N  Mean  s.d.  p 
Effect size 
(Hedges) 
Lower 
Bound 
Upper 
Bound 
CBT  30  -2,7  3,49 
OQ 45.2 Symptom Distress (SD) change from Baseline to Discharge 
BST  30  -3,2  3,04 
0,556  -0,15  -0,66  0,36 
CBT  30  -7,93  5,12 
OQ 45.2 Symptom Distress (SD) change from Discharge to 6 months 
BST  30  -14,1  5,98 
0,000  -1,09  -1,64  -0,55 
CBT  30  -1,5  6,67  OQ 45.2 Interpersonal Relations (IR) change from Baseline to Dis-
charge  BST  30  -4,5  7,78 
0,114  -0,41  -0,92  0,10 
CBT  30  -2,2  10,3  OQ 45.2 Interpersonal Relations (IR) change from Discharge to 6 
months  BST  30  -4,47  10,78 
0,408  -0,21  -0,72  0,29 
CBT  30  -1,77  2,11 
OQ 45.2 Social Role (SR) change from Baseline to Discharge 
BST  30  -1,7  2,93 
0,920  0,03  -0,48  0,53 
CBT  30  -4,33  2,93 
OQ 45.2 Social Role (SR) change from Discharge to 6 months 
BST  30  -5,57  4,38 
0,205  -0,33  -0,84  0,18 
CBT  30  -5,97  6,2 
OQ 45.2 Global Index change from Baseline to Discharge 
BST  30  -9,4  7,46 
0,570  -0,49  -1,01  0,02 
CBT  30  -14,47  12,07 
OQ 45.2 Global Index change from Discharge to 6 months 
BST  30  -27,2  10,91 
0,000  -1,09  -1,63  -0,55 
CBT  30  -6,3  2,36 
Percentage of Weight loss from Baseline to Discharge 
BST  30  -7,12  2,02 
0,152  -0,37  -0,88  0,14 
CBT  30  -11,92  16,9 
Percentage of Weight loss from Baseline to 6 months 
BST  30  -16,93  5,51 
0,128  -0,39  -0,90  0,12 
CBT  30  -5,96  17,90 
Percentage of Weight loss from Discharge to 6 months 
BST  30  -10,53  6,14 
0,191  -0,34  -0,85  0,17 
 
Table 3.  Within-Group Changes of Primary Outcome Measure (OQ 45.2 Global Index) and Secondary Outcome Measures (OQ 
45.2 Sub-Indexes and Weight Loss) at Discharge from the Hospital and after 6 Months by Treatment Group (CBT and 
BST) 
 
95% Confidence Interval of 
the Difference 
Outcomes (Primary and Secondaries)  Group  N  Mean  Std. Deviation  Lower Bound  Upper Bound 
CBT 30  -2,7  3,49  -3,95  -1,45  OQ 45.2 Symptom Distress (SD) change from Baseline to 
Discharge   BST 30  -3,2  3,04  -4,29  -2,11 
CBT 30  -7,93 5,12  -9,77  -6,10  OQ 45.2 Symptom Distress (SD) change from Discharge 
to 6 months  BST 30  -14,1 5,98  -16,24 -11,96 
CBT 30  -1,5  6,67  -3,89  0,89  OQ 45.2 Interpersonal Relations (IR) change from Base-
line to Discharge  BST 30  -4,5  7,78  -7,29  -1,71 34    Clinical Practice & Epidemiology in Mental Health, 2011, Volume 7  Castelnuovo et al. 
Table 3. contd…. 
 
95% Confidence Interval of 
the Difference 
Outcomes (Primary and Secondaries)  Group  N  Mean  Std. Deviation  Lower Bound  Upper Bound 
CBT 30  -2,2  10,3  -5,89  1,49  OQ 45.2 Interpersonal Relations (IR) change from Dis-
charge to 6 months 
BST 30  -4,47  10,78  -8,32  -0,61 
CBT 30  -1,77 2,11  -2,52  -1,01  OQ 45.2 Social Role (SR) change from Baseline to Dis-
charge   BST 30  -1,7  2,93  -2,75  -0,65 
CBT 30  -4,33 2,93  -5,38  -3,29  OQ 45.2 Social Role (SR) change from Discharge to 6 
months  BST 30  -5,57 4,38  -7,13  -4,00 
CBT 30  -5,97  6,2  -8,19  -3,75 
OQ 45.2 Global Index change from Baseline to Discharge 
BST 30  -9,4  7,46  -12,07 -6,73 
CBT 30  -14,47  12,07  -18,79 -10,15 
OQ 45.2 Global Index change from Discharge to 6 months 
BST 30  -27,2  10,91  -31,10 -23,30 
CBT 30  -6,3  2,36  -7,14  -5,45  Percentage of Weight loss (change) from Baseline to Dis-
charge  BST 30  -7,12 2,02  -7,85  -6,40 
CBT 30  -11,92  16,9  -17,97 -5,87  Percentage of Weight loss (change) from Baseline to 6 
months  BST 30  -16,93  5,51  -18,91 -14,96 
CBT 30  -5,96 17,9  -12,36  0,45  Percentage of Weight loss (change) from Discharge to 6 
months  BST 30  -10,53  6,14  -12,73 -8,33 
 
 
 
Note: A significant difference (p <.01) between CBT and BST were found only at 6 months 
 
Fig. (1). Global Index of the OQ 45.2 at baseline, at discharge from the hospital and after 6 months by Treatment Group (CBT and BST)*. STRATOB: a RCT of CBT and BST for Obese Patients with BED  Clinical Practice & Epidemiology in Mental Health, 2011, Volume 7    35 
 
    Note: No significant differences between CBT and BST were found at the 3 time-points 
 
Fig. (2). Change in weight (weight loss) at baseline, at discharge from the hospital and after 6 months by Treatment Group (CBT and BST)*. 
 
 
Note: BED remission was defined as a number of weekly binge episodes < 2.  
 
Fig. (3). Percentage of individuals not remitted at 6 months by Treatment Group (CBT and BST). 
in different ways that have to be investigated in future re-
searches. 
Another study limitation concerns the low number of 
psychometric tools used in the evaluation of change. Even if 
the the OQ 45.2 is designed to collect repeated measures of 
patient progress during psychotherapy and after its conclu-
sion, no specific scale or questionnaire was used to assess 
the eating dysfunctional area of patients. Number of weekly 
binge episodes was used as a simple index for BED remis-
sion and data showed that BST was more effective than CBT 
in preventing relapse, but in future trials the more reliable 
number of weekly binge days (and not the number of weekly 
binge episodes, as suggested by Wilson and Sysko [60]) 
should be used. 
A final limitation is small sample size. Even if this is the 
first study that compared CBT with BST in the treatment of 
BED, larger clinical trials are needed in order to evaluate 
both the effectiveness of integrated psychotherapies (such as 
the traditional CBT combined with BST or IPT) and the use 
of new technologies in the clinical field (from the “low tech-
nology” telephone to the “medium technology” clinically 
oriented SMS, MMS, e-mail, chat, web sources, till the “high 
technology” web 2.0 or virtual and augmented realities) [61-
67]. 36    Clinical Practice & Epidemiology in Mental Health, 2011, Volume 7  Castelnuovo et al. 
Given that the STRATOB trial was a single-centre ran-
domized controlled study, generalization of research findings 
is limited. Future multi-centre trials should extend both the 
use of alternative models of psychological support or psy-
chotherapy, i.e. BST, and the implementation of new tech-
nologies in order to find the best combination of the vari-
ables involved (psychotherapeutic model, level of technol-
ogy, number of sessions, etc.). 
Considering that traditional interventions for BED pa-
tients with obesity typically fails because of low compliance 
with clinical programs, continuous monitoring and psycho-
logical support are needed. This study improved the evi-
dence-based knowledge of how CBT and BST may enhance 
the long-term efficacy of clinical interventions for BED and 
weight loss also using telecare settings. Due to the growing 
development of technologies in the clinical applications, we 
are moving towards a new “health care everywhere” ap-
proach, where clinicians could provide their treatments in 
both traditional clinical settings (public and private hospitals, 
clinics, services, etc.) and innovative clinical settings (re-
mote outpatients’ clinics, tele-health and e-health based set-
tings). 
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